Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.60
Bid: 19.40
Ask: 19.70
Change: 0.19 (0.98%)
Spread: 0.30 (1.546%)
Open: 19.42
High: 19.60
Low: 19.42
Prev. Close: 19.41
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Dec 2019 11:30

RNS Number : 3754W
Nanoco Group PLC
10 December 2019
 

10 December 2019

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

 

Notice of transactions by persons discharging managerial responsibility

As set out in the Company's 2019 Annual Report, and in the RNS on 1 November 2019 detailing an initial grant of deferred share awards in respect of the Executive Directors' annual bonuses for FY19, the Board was seeking shareholder approval for a resolution at the AGM on 5 December 2019 to amend the remuneration policy to allow up to 100% of any annual bonus earned to be paid in deferred share awards. The previous policy was a maximum of 50% in deferred shares with the balance to be paid in cash. The Board consider this change to be in the best interests of the Company by creating additional scope to conserve cash resources.

The relevant resolution was approved by shareholders at the AGM on 5th December 2019 with 99.8% of votes cast in favour. Subject to and following this approval, Nanoco has now granted to the Executive Directors, nil-cost options over ordinary shares in the Company in respect of the second half their annual bonus awards for FY19 as set out below.

Name of Director

Number of options granted

Michael Edelman (CEO)

731,151

Nigel Pickett (CTO)

437,681

Brian Tenner (COO / CFO)

521,634

For the avoidance of doubt, the approved policy amendment had no impact on the actual amount or maximum amount of bonus that was earned in FY19 or can be earned in future years.

Ordinarily, the options will vest following the announcement of Nanoco's results for its financial year ending 31 July 2021. There are no further performance conditions attached to these options.

This notification is made pursuant to Disclosure and Transparency Rule 3.1.4. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

For further information, please contact:

Nanoco Group PLC

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Brian Tenner, Chief Financial Officer

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials through an extensive and unique IP portfolio of over 750 patents and patents pending with world leading R&D capabilities and high capacity production facilities. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

MICHAEL EDELMAN

2.

Reason for the notification

a)

Position /status

CHIEF EXECUTIVE OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

731,151

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

10 December 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

DR NIGEL PICKETT

2.

Reason for the notification

a)

Position /status

CHIEF TECHNICAL OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

437,681

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

10 December 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

BRIAN TENNER

2.

Reason for the notification

a)

Position /status

CHIEF OPERATING OFFICER & CHIEF FINANCIAL OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

521,634

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

10 December 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKKDDDBDDQBD
Date   Source Headline
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return
7th Dec 20233:23 pmRNSResult of AGM
7th Dec 20237:00 amRNSAGM Statement & Trading Update
15th Nov 20237:00 amRNSFirst ever commercial production order
13th Nov 20234:28 pmRNS2023 Annual Report and Notice of AGM
7th Nov 20237:00 amRNSJoint Development Agreement with Asian Customer
2nd Nov 20232:18 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSUnaudited Preliminary Results
10th Oct 20237:00 amRNSNotice of Results
3rd Oct 20234:32 pmRNSForeign Currency Hedge of Litigation Settlement
14th Aug 20233:58 pmRNSResult of Meeting
8th Aug 20237:00 amRNSTrading Update
7th Aug 20237:00 amRNSGlass Lewis recommends to support Nanoco’s Board
2nd Aug 20237:00 amRNSHolding(s) in Company
2nd Aug 20237:00 amRNSISS recommendation to support Nanoco’s Board
1st Aug 20237:13 amRNSTotal Voting Rights
28th Jul 20235:23 pmRNSDirector/PDMR Shareholding
25th Jul 20232:55 pmRNSPublication of Shareholder Presentation
25th Jul 202312:52 pmRNSNanoco Group Plc
24th Jul 20237:00 amRNSHigh Court Confirmation of Capital Reduction
20th Jul 20237:00 amRNSNotification of Investor Presentation
18th Jul 20237:00 amRNSPosting of Circular and Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.